XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)
Conversion of Convertible Notes into Common Stock [Member]
Common Stock [Member]
Conversion of Convertible Notes into Common Stock [Member]
Additional Paid-in Capital [Member]
Conversion of Convertible Notes into Common Stock [Member]
Retained Earnings [Member]
Conversion of Convertible Notes into Common Stock [Member]
Conversion of Related Party Convertible Notes into Common stock [Member]
Common Stock [Member]
Conversion of Related Party Convertible Notes into Common stock [Member]
Additional Paid-in Capital [Member]
Conversion of Related Party Convertible Notes into Common stock [Member]
Retained Earnings [Member]
Conversion of Related Party Convertible Notes into Common stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balances (in shares) at Dec. 31, 2019                 26,953,363      
Balances at Dec. 31, 2019                 $ 0 $ 15,775,010 $ (41,310,172) $ (25,535,162)
Stock-based compensation (in shares)                 0      
Stock-based compensation                 $ 0 393,300 0 393,300
Issuance of common stock – interest shares (in shares)                 90,000      
Issuance of common stock – interest shares                 $ 0 64,800 0 64,800
Issuance of common stock - consulting (in shares)                 225,000      
Issuance of common stock - consulting                 $ 0 162,000 0 162,000
Issuance of common stock - settlement of accrued liability (in shares)                 0      
Issuance of common stock - settlement of accrued liability                 $ 0 58,500 0 58,500
Net loss                 $ 0 0 (2,959,993) (2,959,993)
Balances (in shares) at Jun. 30, 2020                 27,268,363      
Balances at Jun. 30, 2020                 $ 0 16,453,610 (44,270,165) (27,816,555)
Balances (in shares) at Mar. 31, 2020                 26,998,363      
Balances at Mar. 31, 2020                 $ 0 16,004,060 (42,610,284) (26,606,224)
Stock-based compensation (in shares)                 0      
Stock-based compensation                 $ 0 196,650 0 196,650
Issuance of common stock – interest shares (in shares)                 45,000      
Issuance of common stock – interest shares                 $ 0 32,400 0 32,400
Issuance of common stock - consulting (in shares)                 225,000      
Issuance of common stock - consulting                 $ 0 162,000 0 162,000
Issuance of common stock - settlement of accrued liability (in shares)                 0      
Issuance of common stock - settlement of accrued liability                 $ 0 58,500 0 58,500
Net loss                 $ 0 0 (1,659,881) (1,659,881)
Balances (in shares) at Jun. 30, 2020                 27,268,363      
Balances at Jun. 30, 2020                 $ 0 16,453,610 (44,270,165) (27,816,555)
Balances (in shares) at Dec. 31, 2020                 27,557,363      
Balances at Dec. 31, 2020                 $ 0 17,068,810 (27,060,527) (9,991,717)
Stock-based compensation (in shares)                 11,409,291      
Stock-based compensation                 $ 0 15,001,322 0 15,001,322
Issuance of common stock – interest shares (in shares)                 90,000      
Issuance of common stock – interest shares                 $ 0 103,350 0 103,350
Issuance of common stock - consulting (in shares)                 650,000      
Issuance of common stock - consulting                 $ 0 897,000 0 897,000
Issuance of common stock - settlement of accrued liability (in shares)                 8,369      
Issuance of common stock - settlement of accrued liability                 $ 0 13,390 0 13,390
Net loss                 0 0 (16,116,200) (16,116,200)
Beneficial conversion feature on convertible notes issued                 $ 0 111,306 0 111,306
Issuance of common stock – upon conversion of convertible notes (in shares) 3,290,180       42,500              
Issuance of common stock – upon conversion of convertible notes $ 0 $ 4,855,861 $ 0 $ 4,855,861 $ 0 $ 68,000 $ 0 $ 68,000        
Issuance of common stock – settlement of accrued interest (in shares)                 94,357      
Issuance of common stock – settlement of accrued interest                 $ 0 78,893 0 78,893
Balances (in shares) at Jun. 30, 2021                 43,142,060      
Balances at Jun. 30, 2021                 $ 0 38,197,932 (43,176,727) (4,978,795)
Balances (in shares) at Mar. 31, 2021                 27,610,732      
Balances at Mar. 31, 2021                 $ 0 17,220,050 (27,683,562) (10,463,512)
Stock-based compensation (in shares)                 11,409,291      
Stock-based compensation                 $ 0 14,925,572 0 14,925,572
Issuance of common stock – interest shares (in shares)                 45,000      
Issuance of common stock – interest shares                 $ 0 41,250 0 41,250
Issuance of common stock - consulting (in shares)                 650,000      
Issuance of common stock - consulting                 $ 0 897,000 0 897,000
Net loss                 0 0 (15,493,165) (15,493,165)
Beneficial conversion feature on convertible notes issued                 $ 0 111,306 0 111,306
Issuance of common stock – upon conversion of convertible notes (in shares) 3,290,180       42,500              
Issuance of common stock – upon conversion of convertible notes $ 0 $ 4,855,861 $ 0 $ 4,855,861 $ 0 $ 68,000 $ 0 $ 68,000        
Issuance of common stock – settlement of accrued interest (in shares)       94,357         94,357      
Issuance of common stock – settlement of accrued interest                 $ 0 78,893 0 78,893
Balances (in shares) at Jun. 30, 2021                 43,142,060      
Balances at Jun. 30, 2021                 $ 0 $ 38,197,932 $ (43,176,727) $ (4,978,795)